Clinical Trial

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Study acronym: PEPSI
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This randomized controlled study is to evaluate the effectiveness of inhaling penehyclidine hydrochloride in reducing perioperative respiratory adverse events in children at risk undergoing minor elective surgery.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-06-30 -> 2026-08-31 2026-04-07
Trial Details
NCT Number NCT06624696
Lead Sponsor Sun Yat-sen University
Collaborators: Shenzhen Eye Hospital
Conditions Respiratory Hypersensitivity, Perioperative Respiratory Adverse Events, Anticholinergics, Inhalation Therapy; Complications, High Risk
Enrollment 204 participants
Start Date 2024-11-12
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14